Last week, MedGyn’s VP of Global Sales Gene Spahija presented at the Illinois Department of Commerce discussion on the Africa Continental Free Trade Area (AfCFTA). Several key attendees participated including the Secretary General of AfCFTA. Gene traveled with the Illinois Trade Office earlier in the year to Ethiopia and Kenya and participated in the discussion to share MedGyn efforts to promote cervical cancer screening and treatment in Africa. He explained the support MedGyn received from government institutions to identify global partners which allowed the MedGyn Cryotherapy System (MGC-200) to be available to women in need of treatment. The MGC-200 device operated by CO2 or N20 gas is unlike any device available with its unique features including: instant defrost, three-position trigger and extensive range of autoclavable tips. The device has received favorable results from NGOs and distribution partners throughout the world which often makes it the system of choice.
Recently MedGyn, in conjunction with physicians and engineers, has developed the MTA-100 for thermal ablation treatment which establishes a new standard for the market with its unique and key features. The device has a robust, ergonomic design that is portable and battery operated. The MTA-100 also has a large digital display with user friendly programmable buttons for 20, 40 or 60 second treatments at 100̊C. Additionally, the device has a ring of superior LED illumination as well as an extensive range of interchangeable and autoclavable gold coated tips.
Gene was able to discuss MedGyn’s journey to treat women with cervical cancer but also kindly offered advice to other Illinois companies looking to establish new partners in various regions in Africa. He expressed the importance of government institutions and having their support. MedGyn’s presence in international markets was also recognized as MedGyn received the State of Illinois Exporter of the Year in 2019 and 2015.
